PMID: 1370765Jan 1, 1992Paper

Reversal of multidrug resistance by an immunosuppressive agent FK-506

Cancer Chemotherapy and Pharmacology
M NaitoT Tsuruo


FK-506, a novel immunosuppressive agent, was examined for its reversing effect on multidrug-resistant tumor cells. FK-506 at 3 microM completely reversed the resistance against vincristine (VCR) in vitro in VCR-resistant mouse leukemia P388 cells (P388/VCR). FK-506 also enhanced the cytotoxicity of VCR in Adriamycin(ADM)-resistant human ovarian cancer A2780 cells (AD10) and ADM-resistant human myelogenous leukemia K562 cells (K562/ADM) in vitro. FK-506 was also effective in modulating sensitivity to ADM in AD10 cells in vitro. FK-506 enhanced the chemotherapeutic effect of VCR in P388/VCR-bearing mice. When 20 mg/kg FK-506 was combined with 200 micrograms/kg VCR, a T/C value of 151% was obtained. Under the protocol used in this study, FK-506 was more potent than cyclosporin A (CsA) and verapamil. FK-506 inhibited [3H]azidopine binding to P-glycoprotein efficiently. The binding of VCR to K562/ADM plasma membrane was inhibited by FK-506 as effectively as by CsA. Moreover, the accumulation of VCR in AD10 cells was increased by FK-506 as efficiently as that of CsA and verapamil. These results indicate that FK-506 directly interacts with P-glycoprotein like CsA and verapamil, inhibits the active efflux of vincristine from resistant ...Continue Reading


Jun 1, 1990·British Journal of Haematology·P Sonneveld, K Nooter
Jan 1, 1989·Annual Review of Biochemistry·J A Endicott, V Ling
Mar 1, 1988·Japanese Journal of Cancer Research : Gann·T Tsuruo
Apr 1, 1986·The Journal of Clinical Investigation·L M SlaterS Gupta
May 28, 1987·The New England Journal of Medicine·I Pastan, M Gottesman
Jan 1, 1982·Immunological Reviews·S Britton, R Palacios

❮ Previous
Next ❯


Jan 1, 1993·Cytotechnology·J M Ford, W N Hait
Jan 1, 1995·Journal of Cancer Research and Clinical Oncology·M Naito, T Tsuruo
Jan 1, 1993·Mutation Research·L R Ferguson, B C Baguley
Jan 28, 2004·European Journal of Pharmacology·Emiko AsakuraTakaaki Hasegawa
Jun 13, 2002·Il Farmaco·E TeodoriF Gualtieri
Aug 12, 1998·Obstetrics and Gynecology·A K Sood, R E Buller
May 30, 2001·Transplantation Proceedings·T van GelderR E Morris
Feb 19, 2003·The Journal of Steroid Biochemistry and Molecular Biology·Jeanette I Webster, Jan Carlstedt-Duke
Jun 1, 1995·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·V P Zav'yalovT Korpela
Sep 5, 2006·Cancer Research·Adam I MarcusParaskevi Giannakakou
Oct 7, 2004·European Journal of Pharmacology·Akemi ShimizuTakaaki Hasegawa
Nov 21, 2001·Japanese Journal of Cancer Research : Gann·K KurosawaT Tsuruo
Feb 1, 1996·Japanese Journal of Cancer Research : Gann·T WatanabeT Tsuruo
Oct 1, 1995·Journal of Pharmaceutical Sciences·E NakashimaF Ichimura
Jul 19, 1996·The Journal of Biological Chemistry·A Kralli, K R Yamamoto
Feb 14, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Lanying PanSu Zeng
Jul 20, 2000·Clinical and Experimental Pharmacology & Physiology·L WangT Hasegawa
Mar 22, 2002·Clinical and Experimental Pharmacology & Physiology·Ying Lan ZhaoTakaaki Hasegawa
Jul 29, 1996·International Journal of Cancer. Journal International Du Cancer·M NaitoT Tsuruo
Jul 1, 1997·Clinical Pharmacology and Therapeutics·L C FlorenM F Hebert
Aug 22, 2007·International Journal of Cancer. Journal International Du Cancer·Toshio SasajimaKazuo Mizoi
Aug 2, 1996·The Journal of Biological Chemistry·C S Hemenway, J Heitman
Mar 28, 2008·Therapeutic Drug Monitoring·Eric ThervetPhilippe Beaune
Sep 14, 2018·International Journal of Molecular Sciences·Ángelo TorresClaudia Quezada
Jan 1, 1993·Immunopharmacology and Immunotoxicology·M S YanX H Piao

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.